|
RAB3GAP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.19309999999195E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.083980E-02 |
| Normal-vs-Stage2 |
1.427520E-02 |
| Normal-vs-Stage3 |
7.90860000043914E-07 |
| Normal-vs-Stage4 |
1.29729999998052E-06 |
| Stage1-vs-Stage2 |
3.086400E-01 |
| Stage1-vs-Stage3 |
1.444200E-03 |
| Stage1-vs-Stage4 |
1.443190E-03 |
| Stage2-vs-Stage3 |
2.365000E-01 |
| Stage2-vs-Stage4 |
1.661950E-01 |
| Stage3-vs-Stage4 |
7.143400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.18629999999753E-05 |
| Normal-vs-AfricanAmerican |
2.449200E-04 |
| Normal-vs-Asian |
8.276800E-01 |
| Caucasian-vs-AfricanAmerican |
2.362600E-01 |
| Caucasian-vs-Asian |
1.743030E-01 |
| AfricanAmerican-vs-Asian |
7.731600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.30579999996417E-06 |
| Normal-vs-Female |
3.319200E-03 |
| Male-vs-Female |
1.066600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.232300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.424100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.59690999999018E-05 |
| Normal-vs-Age(81-100Yrs) |
1.301910E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.915200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.120800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.852800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.423750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.639040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.036200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.057600E-01 |
| Normal-vs-Grade 2 |
1.472170E-02 |
| Normal-vs-Grade 3 |
2.76290000000845E-06 |
| Normal-vs-Grade 4 |
7.64369999517456E-08 |
| Grade 1-vs-Grade 2 |
4.339900E-02 |
| Grade 1-vs-Grade 3 |
2.442800E-03 |
| Grade 1-vs-Grade 4 |
1.578680E-04 |
| Grade 2-vs-Grade 3 |
8.863700E-03 |
| Grade 2-vs-Grade 4 |
1.999230E-04 |
| Grade 3-vs-Grade 4 |
5.721900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.274400E-01 |
| Normal-vs-ccB subtype |
8.72889999947724E-07 |
| ccA subtype-vs-ccB subtype |
1.67444999999988E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.017480E-04 |
| Normal-vs-N1 |
1.949950E-01 |
| N0-vs-N1 |
9.433400E-01 |
|
|
